7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
US5169857A · kind A · utility
42Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 1990 |
| Grant date | Dec 8, 1992 |
| Priority date | — |
| Expiry date | Dec 13, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis of the formula ##STR1## in which A, B, D and E can have varied meanings, PA0 X is --CH.sub.2 --CH.sub.2 or --CH.dbd.CH--, and PA0 R is ##STR2## wherein R.sup.21 denotes hydrogen or alkyl and PA0 R.sup.22 PA1 denotes hydrogen, PA1 deontes alkyl, aryl or aralkyl, or PA1 denotes a cation, and their oxidation products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.